16-15596809-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014647.4(MARF1):c.5113G>A(p.Glu1705Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000237 in 1,613,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014647.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152118Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000882 AC: 22AN: 249494 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.000251 AC: 367AN: 1461796Hom.: 0 Cov.: 31 AF XY: 0.000235 AC XY: 171AN XY: 727202 show subpopulations
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152118Hom.: 0 Cov.: 33 AF XY: 0.0000942 AC XY: 7AN XY: 74304 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5113G>A (p.E1705K) alteration is located in exon 27 (coding exon 26) of the KIAA0430 gene. This alteration results from a G to A substitution at nucleotide position 5113, causing the glutamic acid (E) at amino acid position 1705 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at